Olanzapine monotherapy for acute depression in patients with bipolar I or II disorder: Results of an 8-week open label trial

William V. Bobo, Richard A. Epstein, Richard C. Shelton

Research output: Contribution to journalArticlepeer-review

12 Scopus citations

Fingerprint

Dive into the research topics of 'Olanzapine monotherapy for acute depression in patients with bipolar I or II disorder: Results of an 8-week open label trial'. Together they form a unique fingerprint.

Medicine & Life Sciences